miR-218-5p and miR-320a-5p as Biomarkers for Brain Disorders: Focus on the Major Depressive Disorder and Parkinson’s Disease
Zhirong Wan(Aerospace Center Hospital), Yulin Deng(Beijing Institute of Technology), Madiha Rasheed(Beijing Institute of Technology), Qin Li(Motac Neuroscience (United Kingdom)), Yumeng Li(Tianjin Institute of Industrial Biotechnology), Zixuan Chen(Beijing Institute of Technology), Jichen Du(King University), Peifu Wang(Peking University), Jilai Li(Aerospace Center Hospital)
Cited by 15
Related Papers
Progress in Understanding Oxidative Stress, Aging, and Aging-Related Diseases
|Antioxidants|2024|222
Luteolin-loaded solid lipid nanoparticles synthesis, characterization, & improvement of bioavailability, pharmacokinetics in vitro and vivo studies
|Journal of Nanoparticle Research|2014|128
Pharmacological Modulation of Nrf2/HO-1 Signaling Pathway as a Therapeutic Target of Parkinson’s Disease
|Frontiers in Pharmacology|2021|95
Hypertrophic olivary degeneration: A comprehensive review focusing on etiology
|Brain Research|2019|73